{
    "organizations": [],
    "uuid": "c0a0aa825a0d181a6d94f0292882ccd1d7049f89",
    "author": "",
    "url": "https://www.reuters.com/article/brief-hemostemix-announces-departure-of/brief-hemostemix-announces-departure-of-david-berman-as-cfo-idUSASC09ZJS",
    "ord_in_thread": 0,
    "title": "BRIEF-Hemostemix Announces Departure Of David Berman As CFO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3, 2018 / 12:40 PM / Updated 13 minutes ago BRIEF-Hemostemix Announces Departure Of David Berman As CFO Reuters Staff\nMay 3 (Reuters) - Hemostemix Inc:\n* HEMOSTEMIX ANNOUNCES FIRST PATIENT TREATED IN PHASE II CLINICAL TRIAL\n* HEMOSTEMIX INC - ANNOUNCES DEPARTURE OF DAVID BERMAN FROM POSITION OF CHIEF FINANCIAL OFFICER\n* HEMOSTEMIX INC - KRISTIN GULKA JOINS HEMOSTEMIX IN CAPACITY OF CFO Source text for Eikon: Further company coverage:",
    "published": "2018-05-03T15:39:00.000+03:00",
    "crawled": "2018-05-03T16:00:33.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "departure",
        "david",
        "berman",
        "cfo",
        "reuters",
        "staff",
        "may",
        "reuters",
        "hemostemix",
        "inc",
        "hemostemix",
        "announces",
        "first",
        "patient",
        "treated",
        "phase",
        "ii",
        "clinical",
        "trial",
        "hemostemix",
        "inc",
        "announces",
        "departure",
        "david",
        "berman",
        "position",
        "chief",
        "financial",
        "officer",
        "hemostemix",
        "inc",
        "kristin",
        "gulka",
        "join",
        "hemostemix",
        "capacity",
        "cfo",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}